HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-JUN-14 4TN4 TITLE CRYSTAL STRUCTURE OF TERNARY COMPLEX OF PLASMODIUM VIVAX SHMT WITH TITLE 2 GLYCINE AND A NOVEL PYRAZOLOPYRAN 33G: (4S)-6-AMINO-4-(5-CYANO-3'- TITLE 3 FLUOROBIPHENYL-3-YL)-4-CYCLOBUTYL-3-METHYL-2,4-DIHYDROPYRANO[2,3- TITLE 4 C]PYRAZOLE-5-CARBONITRILE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE HYDROXYMETHYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: PLASMODIUM VIVAX SHMT WITH PLP-GLYCINE SCHIFF BASE AND COMPND 6 A NOVEL PYRAZOLOPYRAN TH2S SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM VIVAX; SOURCE 3 ORGANISM_TAXID: 126793; SOURCE 4 STRAIN: SALVADOR I; SOURCE 5 GENE: PVX_100730; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17B KEYWDS ALPHA AND BETA PROTEIN, TRANSFERASE, METHYLTRANSFERASE ACTIVITY, KEYWDS 2 INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.CHITNUMSUB,A.JARUWAT,U.LEARTSAKULPANICH,M.C.WITSCHEL REVDAT 5 27-SEP-23 4TN4 1 REMARK REVDAT 4 22-NOV-17 4TN4 1 SOURCE JRNL REMARK REVDAT 3 22-APR-15 4TN4 1 JRNL REVDAT 2 01-APR-15 4TN4 1 JRNL REVDAT 1 25-MAR-15 4TN4 0 JRNL AUTH M.C.WITSCHEL,M.ROTTMANN,A.SCHWAB,U.LEARTSAKULPANICH, JRNL AUTH 2 P.CHITNUMSUB,M.SEET,S.TONAZZI,G.SCHWERTZ,F.STELZER, JRNL AUTH 3 T.MIETZNER,C.MCNAMARA,F.THATER,C.FREYMOND,A.JARUWAT, JRNL AUTH 4 C.PINTHONG,P.RIANGRUNGROJ,M.OUFIR,M.HAMBURGER,P.MASER, JRNL AUTH 5 L.M.SANZ-ALONSO,S.CHARMAN,S.WITTLIN,Y.YUTHAVONG,P.CHAIYEN, JRNL AUTH 6 F.DIEDERICH JRNL TITL INHIBITORS OF PLASMODIAL SERINE HYDROXYMETHYLTRANSFERASE JRNL TITL 2 (SHMT): COCRYSTAL STRUCTURES OF PYRAZOLOPYRANS WITH POTENT JRNL TITL 3 BLOOD- AND LIVER-STAGE ACTIVITIES. JRNL REF J.MED.CHEM. V. 58 3117 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25785478 JRNL DOI 10.1021/JM501987H REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 64376 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 6489 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3655 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 416 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10374 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 170 REMARK 3 SOLVENT ATOMS : 482 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : -0.18000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.456 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.292 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.212 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.510 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 10755 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 14541 ; 1.524 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1329 ; 5.790 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 486 ;36.223 ;25.247 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1914 ;17.808 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;18.437 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1611 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8097 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4TN4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000201905. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSRRC REMARK 200 BEAMLINE : BL13B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : RH COATED MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64394 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.01500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 44.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.06500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 4OYT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, 0.06-0.12 M NACL, 0.1 M TRIS REMARK 280 -HCL PH 8.5, VAPOR DIFFUSION, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 50.20600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.99450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 50.20600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.99450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS THE SAME AS ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -83.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 100.41200 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 6 151.64 -45.72 REMARK 500 SER A 55 32.52 -146.06 REMARK 500 LYS A 60 13.31 59.66 REMARK 500 LYS A 61 43.38 -147.06 REMARK 500 ASP A 89 -30.30 -38.91 REMARK 500 LYS A 138 -9.66 92.66 REMARK 500 LYS A 237 -121.06 -87.58 REMARK 500 ASN A 325 -142.96 -128.81 REMARK 500 SER B 55 34.35 -140.37 REMARK 500 LYS B 60 15.17 57.29 REMARK 500 LYS B 61 33.74 -147.79 REMARK 500 LYS B 237 -125.65 -84.15 REMARK 500 ASN B 325 -147.16 -128.88 REMARK 500 SER B 360 -8.11 -59.00 REMARK 500 ARG C 49 -5.09 -58.42 REMARK 500 SER C 55 33.74 -141.62 REMARK 500 ASN C 86 56.87 39.03 REMARK 500 ASP C 146 -51.01 -120.06 REMARK 500 LYS C 237 -122.84 -87.22 REMARK 500 SER C 244 -179.05 -171.21 REMARK 500 ASN C 325 -149.58 -133.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 741 DISTANCE = 5.84 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLG A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 33G A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLG B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 33G B 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLG C 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BME C 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 33G C 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL C 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PFF RELATED DB: PDB REMARK 900 4PFF IS THE CRYSTAL STRUCTURE OF PLASMODIUM VIVAX SHMT IN COMPLEX REMARK 900 WITH PLP SCHIFF BASE. REMARK 900 RELATED ID: 4PFN RELATED DB: PDB REMARK 900 4PFN IS THE CRYSTAL STRUCTURE OF PLASMODIUM VIVAX SHMT IN COMPLEX REMARK 900 WITH L-SERINE. REMARK 900 RELATED ID: 4OYT RELATED DB: PDB REMARK 900 4OYT IS THE CRYSTAL STRUCTURE OF PLASMODIUM VIVAX SHMT IN COMPLEX REMARK 900 WITH D-SERINE AND [6R]-5FTHF. REMARK 900 RELATED ID: 4O6Z RELATED DB: PDB REMARK 900 4O6Z IS THE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM SHMT IN REMARK 900 COMPLEX WITH PLP SCHIFF BASE. REMARK 900 RELATED ID: 4TMR RELATED DB: PDB REMARK 900 4TMR IS THE CRYSTAL STRUCTURE OF PLASMODIUM VIVAX SHMT IN COMPLEX REMARK 900 WITH GLYCINE AND A NOVEL PYRAZOLOPYRAN 99S. DBREF 4TN4 A 1 442 UNP A5K8L9 A5K8L9_PLAVS 1 442 DBREF 4TN4 B 1 442 UNP A5K8L9 A5K8L9_PLAVS 1 442 DBREF 4TN4 C 1 442 UNP A5K8L9 A5K8L9_PLAVS 1 442 SEQRES 1 A 442 MET PHE ASN ASN GLU PRO LEU GLU GLN ILE ASP LYS GLU SEQRES 2 A 442 LEU HIS ASP ILE LEU ALA ASP GLU GLU LYS ARG GLN ARG SEQRES 3 A 442 GLU THR ILE ASN LEU ILE ALA SER GLU ASN LEU THR ASN SEQRES 4 A 442 GLY ALA VAL ARG GLU CYS LEU GLY ASN ARG VAL SER ASN SEQRES 5 A 442 LYS TYR SER GLU GLY TYR PRO LYS LYS ARG TYR TYR GLY SEQRES 6 A 442 GLY ASN ASP PHE ILE ASP LYS ILE GLU GLU LEU CYS GLN SEQRES 7 A 442 LYS ARG ALA LEU GLU ALA PHE ASN VAL SER ASP GLU GLU SEQRES 8 A 442 TRP GLY VAL ASN VAL GLN PRO LEU SER GLY SER ALA ALA SEQRES 9 A 442 ASN VAL GLN ALA LEU TYR ALA LEU VAL GLY VAL LYS GLY SEQRES 10 A 442 LYS ILE MET GLY MET HIS LEU CYS SER GLY GLY HIS LEU SEQRES 11 A 442 THR HIS GLY PHE PHE ASP GLU LYS LYS LYS VAL SER ILE SEQRES 12 A 442 THR SER ASP MET PHE GLU SER LYS LEU TYR LYS CYS ASN SEQRES 13 A 442 SER GLN GLY TYR VAL ASP LEU ASP ALA VAL ARG GLU MET SEQRES 14 A 442 ALA LEU SER PHE LYS PRO LYS VAL ILE ILE CYS GLY TYR SEQRES 15 A 442 THR SER TYR PRO ARG ASP ILE ASP TYR GLN GLN PHE ARG SEQRES 16 A 442 GLN ILE CYS ASP GLU VAL ASN ALA TYR LEU PHE ALA ASP SEQRES 17 A 442 ILE SER HIS ILE SER SER PHE VAL ALA CYS ASN ILE LEU SEQRES 18 A 442 ASN ASN PRO PHE LEU HIS ALA ASP VAL VAL THR THR THR SEQRES 19 A 442 THR HIS LYS ILE LEU ARG GLY PRO ARG SER ALA LEU ILE SEQRES 20 A 442 PHE PHE ASN LYS LYS ARG ASN PRO GLY ILE GLU GLN LYS SEQRES 21 A 442 ILE ASN SER ALA VAL PHE PRO SER PHE GLN GLY GLY PRO SEQRES 22 A 442 HIS ASN ASN LYS ILE ALA ALA VAL ALA CYS GLN LEU LYS SEQRES 23 A 442 GLU VAL HIS SER PRO ALA PHE LYS GLU TYR THR GLN GLN SEQRES 24 A 442 VAL LEU LEU ASN SER LYS ALA LEU ALA LYS ALA LEU ILE SEQRES 25 A 442 SER LYS GLN ILE ASP LEU VAL THR ASN GLY THR ASP ASN SEQRES 26 A 442 HIS LEU ILE VAL VAL ASP LEU ARG LYS PHE SER ILE THR SEQRES 27 A 442 GLY SER LYS LEU GLN GLU THR CYS ASN ALA ILE ASN VAL SEQRES 28 A 442 SER LEU ASN LYS ASN THR ILE PRO SER ASP VAL ASP CYS SEQRES 29 A 442 VAL SER PRO SER GLY VAL ARG ILE GLY THR PRO ALA MET SEQRES 30 A 442 THR THR ARG GLY ALA LYS GLU LYS ASP MET GLU PHE ILE SEQRES 31 A 442 ALA ASP VAL LEU ALA ARG ALA ILE LYS ILE THR VAL ASP SEQRES 32 A 442 LEU GLN GLU GLN TYR GLY LYS LYS LEU VAL ASP PHE LYS SEQRES 33 A 442 LYS GLY LEU PRO GLY ASN ALA GLN LEU GLN GLN LEU LYS SEQRES 34 A 442 GLN GLU VAL VAL THR TRP ALA GLY ALA LEU PRO PHE PRO SEQRES 1 B 442 MET PHE ASN ASN GLU PRO LEU GLU GLN ILE ASP LYS GLU SEQRES 2 B 442 LEU HIS ASP ILE LEU ALA ASP GLU GLU LYS ARG GLN ARG SEQRES 3 B 442 GLU THR ILE ASN LEU ILE ALA SER GLU ASN LEU THR ASN SEQRES 4 B 442 GLY ALA VAL ARG GLU CYS LEU GLY ASN ARG VAL SER ASN SEQRES 5 B 442 LYS TYR SER GLU GLY TYR PRO LYS LYS ARG TYR TYR GLY SEQRES 6 B 442 GLY ASN ASP PHE ILE ASP LYS ILE GLU GLU LEU CYS GLN SEQRES 7 B 442 LYS ARG ALA LEU GLU ALA PHE ASN VAL SER ASP GLU GLU SEQRES 8 B 442 TRP GLY VAL ASN VAL GLN PRO LEU SER GLY SER ALA ALA SEQRES 9 B 442 ASN VAL GLN ALA LEU TYR ALA LEU VAL GLY VAL LYS GLY SEQRES 10 B 442 LYS ILE MET GLY MET HIS LEU CYS SER GLY GLY HIS LEU SEQRES 11 B 442 THR HIS GLY PHE PHE ASP GLU LYS LYS LYS VAL SER ILE SEQRES 12 B 442 THR SER ASP MET PHE GLU SER LYS LEU TYR LYS CYS ASN SEQRES 13 B 442 SER GLN GLY TYR VAL ASP LEU ASP ALA VAL ARG GLU MET SEQRES 14 B 442 ALA LEU SER PHE LYS PRO LYS VAL ILE ILE CYS GLY TYR SEQRES 15 B 442 THR SER TYR PRO ARG ASP ILE ASP TYR GLN GLN PHE ARG SEQRES 16 B 442 GLN ILE CYS ASP GLU VAL ASN ALA TYR LEU PHE ALA ASP SEQRES 17 B 442 ILE SER HIS ILE SER SER PHE VAL ALA CYS ASN ILE LEU SEQRES 18 B 442 ASN ASN PRO PHE LEU HIS ALA ASP VAL VAL THR THR THR SEQRES 19 B 442 THR HIS LYS ILE LEU ARG GLY PRO ARG SER ALA LEU ILE SEQRES 20 B 442 PHE PHE ASN LYS LYS ARG ASN PRO GLY ILE GLU GLN LYS SEQRES 21 B 442 ILE ASN SER ALA VAL PHE PRO SER PHE GLN GLY GLY PRO SEQRES 22 B 442 HIS ASN ASN LYS ILE ALA ALA VAL ALA CYS GLN LEU LYS SEQRES 23 B 442 GLU VAL HIS SER PRO ALA PHE LYS GLU TYR THR GLN GLN SEQRES 24 B 442 VAL LEU LEU ASN SER LYS ALA LEU ALA LYS ALA LEU ILE SEQRES 25 B 442 SER LYS GLN ILE ASP LEU VAL THR ASN GLY THR ASP ASN SEQRES 26 B 442 HIS LEU ILE VAL VAL ASP LEU ARG LYS PHE SER ILE THR SEQRES 27 B 442 GLY SER LYS LEU GLN GLU THR CYS ASN ALA ILE ASN VAL SEQRES 28 B 442 SER LEU ASN LYS ASN THR ILE PRO SER ASP VAL ASP CYS SEQRES 29 B 442 VAL SER PRO SER GLY VAL ARG ILE GLY THR PRO ALA MET SEQRES 30 B 442 THR THR ARG GLY ALA LYS GLU LYS ASP MET GLU PHE ILE SEQRES 31 B 442 ALA ASP VAL LEU ALA ARG ALA ILE LYS ILE THR VAL ASP SEQRES 32 B 442 LEU GLN GLU GLN TYR GLY LYS LYS LEU VAL ASP PHE LYS SEQRES 33 B 442 LYS GLY LEU PRO GLY ASN ALA GLN LEU GLN GLN LEU LYS SEQRES 34 B 442 GLN GLU VAL VAL THR TRP ALA GLY ALA LEU PRO PHE PRO SEQRES 1 C 442 MET PHE ASN ASN GLU PRO LEU GLU GLN ILE ASP LYS GLU SEQRES 2 C 442 LEU HIS ASP ILE LEU ALA ASP GLU GLU LYS ARG GLN ARG SEQRES 3 C 442 GLU THR ILE ASN LEU ILE ALA SER GLU ASN LEU THR ASN SEQRES 4 C 442 GLY ALA VAL ARG GLU CYS LEU GLY ASN ARG VAL SER ASN SEQRES 5 C 442 LYS TYR SER GLU GLY TYR PRO LYS LYS ARG TYR TYR GLY SEQRES 6 C 442 GLY ASN ASP PHE ILE ASP LYS ILE GLU GLU LEU CYS GLN SEQRES 7 C 442 LYS ARG ALA LEU GLU ALA PHE ASN VAL SER ASP GLU GLU SEQRES 8 C 442 TRP GLY VAL ASN VAL GLN PRO LEU SER GLY SER ALA ALA SEQRES 9 C 442 ASN VAL GLN ALA LEU TYR ALA LEU VAL GLY VAL LYS GLY SEQRES 10 C 442 LYS ILE MET GLY MET HIS LEU CYS SER GLY GLY HIS LEU SEQRES 11 C 442 THR HIS GLY PHE PHE ASP GLU LYS LYS LYS VAL SER ILE SEQRES 12 C 442 THR SER ASP MET PHE GLU SER LYS LEU TYR LYS CYS ASN SEQRES 13 C 442 SER GLN GLY TYR VAL ASP LEU ASP ALA VAL ARG GLU MET SEQRES 14 C 442 ALA LEU SER PHE LYS PRO LYS VAL ILE ILE CYS GLY TYR SEQRES 15 C 442 THR SER TYR PRO ARG ASP ILE ASP TYR GLN GLN PHE ARG SEQRES 16 C 442 GLN ILE CYS ASP GLU VAL ASN ALA TYR LEU PHE ALA ASP SEQRES 17 C 442 ILE SER HIS ILE SER SER PHE VAL ALA CYS ASN ILE LEU SEQRES 18 C 442 ASN ASN PRO PHE LEU HIS ALA ASP VAL VAL THR THR THR SEQRES 19 C 442 THR HIS LYS ILE LEU ARG GLY PRO ARG SER ALA LEU ILE SEQRES 20 C 442 PHE PHE ASN LYS LYS ARG ASN PRO GLY ILE GLU GLN LYS SEQRES 21 C 442 ILE ASN SER ALA VAL PHE PRO SER PHE GLN GLY GLY PRO SEQRES 22 C 442 HIS ASN ASN LYS ILE ALA ALA VAL ALA CYS GLN LEU LYS SEQRES 23 C 442 GLU VAL HIS SER PRO ALA PHE LYS GLU TYR THR GLN GLN SEQRES 24 C 442 VAL LEU LEU ASN SER LYS ALA LEU ALA LYS ALA LEU ILE SEQRES 25 C 442 SER LYS GLN ILE ASP LEU VAL THR ASN GLY THR ASP ASN SEQRES 26 C 442 HIS LEU ILE VAL VAL ASP LEU ARG LYS PHE SER ILE THR SEQRES 27 C 442 GLY SER LYS LEU GLN GLU THR CYS ASN ALA ILE ASN VAL SEQRES 28 C 442 SER LEU ASN LYS ASN THR ILE PRO SER ASP VAL ASP CYS SEQRES 29 C 442 VAL SER PRO SER GLY VAL ARG ILE GLY THR PRO ALA MET SEQRES 30 C 442 THR THR ARG GLY ALA LYS GLU LYS ASP MET GLU PHE ILE SEQRES 31 C 442 ALA ASP VAL LEU ALA ARG ALA ILE LYS ILE THR VAL ASP SEQRES 32 C 442 LEU GLN GLU GLN TYR GLY LYS LYS LEU VAL ASP PHE LYS SEQRES 33 C 442 LYS GLY LEU PRO GLY ASN ALA GLN LEU GLN GLN LEU LYS SEQRES 34 C 442 GLN GLU VAL VAL THR TRP ALA GLY ALA LEU PRO PHE PRO HET PLG A 501 20 HET BME A 502 4 HET 33G A 503 32 HET CL A 504 1 HET PLG B 501 20 HET BME B 502 4 HET 33G B 503 32 HET PLG C 501 20 HET BME C 502 4 HET 33G C 503 32 HET CL C 504 1 HETNAM PLG N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL- HETNAM 2 PLG PYRIDIN-4-YL-METHANE] HETNAM BME BETA-MERCAPTOETHANOL HETNAM 33G (4S)-6-AMINO-4-(5-CYANO-3'-FLUOROBIPHENYL-3-YL)-4- HETNAM 2 33G CYCLOBUTYL-3-METHYL-2,4-DIHYDROPYRANO[2,3-C]PYRAZOLE- HETNAM 3 33G 5-CARBONITRILE HETNAM CL CHLORIDE ION HETSYN PLG N-PYRIDOXYL-GLYCINE-5-MONOPHOSPHATE FORMUL 4 PLG 3(C10 H15 N2 O7 P) FORMUL 5 BME 3(C2 H6 O S) FORMUL 6 33G 3(C25 H20 F N5 O) FORMUL 7 CL 2(CL 1-) FORMUL 15 HOH *482(H2 O) HELIX 1 AA1 PRO A 6 ASP A 11 1 6 HELIX 2 AA2 ASP A 11 GLU A 27 1 17 HELIX 3 AA3 ASN A 39 GLY A 47 1 9 HELIX 4 AA4 ASN A 48 LYS A 53 5 6 HELIX 5 AA5 ASN A 67 PHE A 85 1 19 HELIX 6 AA6 SER A 100 GLY A 114 1 15 HELIX 7 AA7 HIS A 129 GLY A 133 5 5 HELIX 8 AA8 SER A 142 ASP A 146 5 5 HELIX 9 AA9 ASP A 162 LYS A 174 1 13 HELIX 10 AB1 ASP A 190 ASN A 202 1 13 HELIX 11 AB2 ILE A 212 CYS A 218 1 7 HELIX 12 AB3 ASN A 223 HIS A 227 5 5 HELIX 13 AB4 GLY A 256 PHE A 266 1 11 HELIX 14 AB5 HIS A 274 HIS A 289 1 16 HELIX 15 AB6 SER A 290 LYS A 314 1 25 HELIX 16 AB7 THR A 320 GLY A 322 5 3 HELIX 17 AB8 ARG A 333 SER A 336 5 4 HELIX 18 AB9 THR A 338 ILE A 349 1 12 HELIX 19 AC1 THR A 374 ARG A 380 1 7 HELIX 20 AC2 LYS A 383 GLY A 409 1 27 HELIX 21 AC3 LYS A 411 GLY A 418 1 8 HELIX 22 AC4 ASN A 422 ALA A 438 1 17 HELIX 23 AC5 PRO B 6 ASP B 11 1 6 HELIX 24 AC6 ASP B 11 GLU B 27 1 17 HELIX 25 AC7 ASN B 39 GLY B 47 1 9 HELIX 26 AC8 ASN B 48 LYS B 53 5 6 HELIX 27 AC9 ASN B 67 PHE B 85 1 19 HELIX 28 AD1 SER B 100 GLY B 114 1 15 HELIX 29 AD2 LEU B 124 GLY B 127 5 4 HELIX 30 AD3 HIS B 129 GLY B 133 5 5 HELIX 31 AD4 SER B 142 ASP B 146 5 5 HELIX 32 AD5 ASP B 162 LYS B 174 1 13 HELIX 33 AD6 ASP B 190 ASN B 202 1 13 HELIX 34 AD7 ILE B 212 CYS B 218 1 7 HELIX 35 AD8 ASN B 223 HIS B 227 5 5 HELIX 36 AD9 GLY B 256 PHE B 266 1 11 HELIX 37 AE1 HIS B 274 SER B 290 1 17 HELIX 38 AE2 SER B 290 LYS B 314 1 25 HELIX 39 AE3 THR B 320 GLY B 322 5 3 HELIX 40 AE4 ARG B 333 SER B 336 5 4 HELIX 41 AE5 THR B 338 ILE B 349 1 12 HELIX 42 AE6 THR B 374 ARG B 380 1 7 HELIX 43 AE7 LYS B 383 LYS B 385 5 3 HELIX 44 AE8 ASP B 386 GLY B 409 1 24 HELIX 45 AE9 LYS B 411 LYS B 417 1 7 HELIX 46 AF1 ASN B 422 ALA B 438 1 17 HELIX 47 AF2 PRO C 6 ASP C 11 1 6 HELIX 48 AF3 ASP C 11 GLU C 27 1 17 HELIX 49 AF4 ASN C 39 GLY C 47 1 9 HELIX 50 AF5 ASN C 48 LYS C 53 5 6 HELIX 51 AF6 ASN C 67 PHE C 85 1 19 HELIX 52 AF7 SER C 100 GLY C 114 1 15 HELIX 53 AF8 LEU C 124 GLY C 127 5 4 HELIX 54 AF9 HIS C 129 GLY C 133 5 5 HELIX 55 AG1 SER C 142 ASP C 146 5 5 HELIX 56 AG2 ASP C 162 LYS C 174 1 13 HELIX 57 AG3 ASP C 190 ASN C 202 1 13 HELIX 58 AG4 ILE C 212 CYS C 218 1 7 HELIX 59 AG5 ASN C 223 HIS C 227 5 5 HELIX 60 AG6 GLY C 256 PHE C 266 1 11 HELIX 61 AG7 HIS C 274 HIS C 289 1 16 HELIX 62 AG8 SER C 290 LYS C 314 1 25 HELIX 63 AG9 THR C 320 GLY C 322 5 3 HELIX 64 AH1 ARG C 333 SER C 336 5 4 HELIX 65 AH2 THR C 338 ILE C 349 1 12 HELIX 66 AH3 THR C 374 ARG C 380 1 7 HELIX 67 AH4 LYS C 383 GLY C 409 1 27 HELIX 68 AH5 LYS C 411 LYS C 417 1 7 HELIX 69 AH6 ASN C 422 ALA C 438 1 17 SHEET 1 AA1 2 ILE A 29 ASN A 30 0 SHEET 2 AA1 2 VAL A 351 SER A 352 1 O SER A 352 N ILE A 29 SHEET 1 AA2 2 GLY A 57 TYR A 58 0 SHEET 2 AA2 2 LYS A 61 ARG A 62 -1 O LYS A 61 N TYR A 58 SHEET 1 AA3 7 TRP A 92 ASN A 95 0 SHEET 2 AA3 7 ALA A 245 ASN A 250 -1 O PHE A 249 N GLY A 93 SHEET 3 AA3 7 VAL A 230 THR A 234 -1 N VAL A 231 O PHE A 248 SHEET 4 AA3 7 TYR A 204 ASP A 208 1 N ALA A 207 O VAL A 230 SHEET 5 AA3 7 VAL A 177 CYS A 180 1 N CYS A 180 O ASP A 208 SHEET 6 AA3 7 LYS A 118 MET A 122 1 N MET A 120 O ILE A 179 SHEET 7 AA3 7 GLU A 149 TYR A 153 1 O GLU A 149 N ILE A 119 SHEET 1 AA4 4 ASP A 317 LEU A 318 0 SHEET 2 AA4 4 LEU A 327 ASP A 331 -1 O ASP A 331 N ASP A 317 SHEET 3 AA4 4 GLY A 369 GLY A 373 -1 O VAL A 370 N VAL A 330 SHEET 4 AA4 4 ASN A 354 ASN A 356 -1 N ASN A 354 O ARG A 371 SHEET 1 AA5 2 ILE B 29 ASN B 30 0 SHEET 2 AA5 2 VAL B 351 SER B 352 1 O SER B 352 N ILE B 29 SHEET 1 AA6 2 GLY B 57 TYR B 58 0 SHEET 2 AA6 2 LYS B 61 ARG B 62 -1 O LYS B 61 N TYR B 58 SHEET 1 AA7 7 TRP B 92 ASN B 95 0 SHEET 2 AA7 7 ALA B 245 ASN B 250 -1 O PHE B 249 N GLY B 93 SHEET 3 AA7 7 VAL B 230 THR B 234 -1 N VAL B 231 O PHE B 248 SHEET 4 AA7 7 TYR B 204 ASP B 208 1 N ALA B 207 O VAL B 230 SHEET 5 AA7 7 VAL B 177 CYS B 180 1 N CYS B 180 O PHE B 206 SHEET 6 AA7 7 LYS B 118 MET B 122 1 N MET B 120 O ILE B 179 SHEET 7 AA7 7 GLU B 149 TYR B 153 1 O TYR B 153 N GLY B 121 SHEET 1 AA8 4 ASP B 317 LEU B 318 0 SHEET 2 AA8 4 LEU B 327 ASP B 331 -1 O ASP B 331 N ASP B 317 SHEET 3 AA8 4 GLY B 369 GLY B 373 -1 O ILE B 372 N ILE B 328 SHEET 4 AA8 4 ASN B 354 ASN B 356 -1 N ASN B 354 O ARG B 371 SHEET 1 AA9 2 ILE C 29 ASN C 30 0 SHEET 2 AA9 2 VAL C 351 SER C 352 1 O SER C 352 N ILE C 29 SHEET 1 AB1 2 GLY C 57 TYR C 58 0 SHEET 2 AB1 2 LYS C 61 ARG C 62 -1 O LYS C 61 N TYR C 58 SHEET 1 AB2 7 TRP C 92 ASN C 95 0 SHEET 2 AB2 7 ALA C 245 ASN C 250 -1 O PHE C 249 N GLY C 93 SHEET 3 AB2 7 VAL C 230 THR C 234 -1 N VAL C 231 O PHE C 248 SHEET 4 AB2 7 TYR C 204 ASP C 208 1 N ALA C 207 O VAL C 230 SHEET 5 AB2 7 VAL C 177 CYS C 180 1 N CYS C 180 O ASP C 208 SHEET 6 AB2 7 GLY C 117 MET C 122 1 N MET C 120 O ILE C 179 SHEET 7 AB2 7 PHE C 148 TYR C 153 1 O GLU C 149 N GLY C 117 SHEET 1 AB3 4 ASP C 317 LEU C 318 0 SHEET 2 AB3 4 LEU C 327 ASP C 331 -1 O ASP C 331 N ASP C 317 SHEET 3 AB3 4 GLY C 369 GLY C 373 -1 O ILE C 372 N ILE C 328 SHEET 4 AB3 4 ASN C 354 ASN C 356 -1 N ASN C 354 O ARG C 371 SSBOND 1 CYS A 218 BME A 502 1555 1555 2.20 SSBOND 2 CYS B 218 BME B 502 1555 1555 2.20 SSBOND 3 CYS C 218 BME C 502 1555 1555 2.19 CISPEP 1 PHE A 266 PRO A 267 0 15.27 CISPEP 2 PHE B 266 PRO B 267 0 9.39 CISPEP 3 PHE C 266 PRO C 267 0 12.38 SITE 1 AC1 18 SER A 34 SER A 100 GLY A 101 SER A 102 SITE 2 AC1 18 HIS A 129 THR A 183 ASP A 208 SER A 210 SITE 3 AC1 18 HIS A 211 HIS A 236 LYS A 237 ARG A 371 SITE 4 AC1 18 HOH A 643 HOH A 660 TYR B 54 TYR B 64 SITE 5 AC1 18 GLY B 271 GLY B 272 SITE 1 AC2 8 ALA A 84 ASN A 86 ALA A 217 CYS A 218 SITE 2 AC2 8 VAL A 288 HIS A 289 LYS A 294 HOH A 680 SITE 1 AC3 11 LEU A 124 GLY A 127 GLY A 128 HIS A 129 SITE 2 AC3 11 THR A 183 ASN A 354 LYS A 355 ASN A 356 SITE 3 AC3 11 GLU B 56 TYR B 63 TYR B 64 SITE 1 AC4 4 ASN A 276 LYS A 277 ASN B 276 LYS B 277 SITE 1 AC5 19 TYR A 54 TYR A 64 GLY A 272 SER B 34 SITE 2 AC5 19 SER B 100 GLY B 101 SER B 102 HIS B 129 SITE 3 AC5 19 TYR B 182 THR B 183 ASP B 208 SER B 210 SITE 4 AC5 19 HIS B 211 THR B 234 HIS B 236 LYS B 237 SITE 5 AC5 19 ARG B 371 HOH B 640 HOH B 647 SITE 1 AC6 7 ALA B 84 ASN B 86 ALA B 217 CYS B 218 SITE 2 AC6 7 VAL B 288 HIS B 289 LYS B 294 SITE 1 AC7 10 GLU A 56 TYR A 63 TYR A 64 LEU B 124 SITE 2 AC7 10 GLY B 128 HIS B 129 THR B 183 ASN B 354 SITE 3 AC7 10 LYS B 355 ASN B 356 SITE 1 AC8 20 SER C 34 TYR C 54 TYR C 64 SER C 100 SITE 2 AC8 20 GLY C 101 SER C 102 HIS C 129 TYR C 182 SITE 3 AC8 20 THR C 183 ASP C 208 SER C 210 HIS C 211 SITE 4 AC8 20 THR C 234 HIS C 236 LYS C 237 GLY C 271 SITE 5 AC8 20 GLY C 272 ARG C 371 HOH C 632 HOH C 654 SITE 1 AC9 7 ALA C 84 ASN C 86 ALA C 217 CYS C 218 SITE 2 AC9 7 VAL C 288 HIS C 289 LYS C 294 SITE 1 AD1 13 GLU C 56 TYR C 63 TYR C 64 LEU C 124 SITE 2 AD1 13 GLY C 127 GLY C 128 HIS C 129 THR C 183 SITE 3 AD1 13 ASN C 354 LYS C 355 ASN C 356 PRO C 367 SITE 4 AD1 13 HOH C 601 SITE 1 AD2 2 ASN C 276 LYS C 277 CRYST1 100.412 57.989 236.955 90.00 89.99 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009959 0.000000 -0.000002 0.00000 SCALE2 0.000000 0.017245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004220 0.00000